Terns Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US8808811074
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityTERN / Terns Pharmaceuticals, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership805,236 shares
Latest Disclosed Value $ 42,452,042
Northern Trust Corp reports 21.19% increase in ownership of TERN / Terns Pharmaceuticals, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 805,236 shares of Terns Pharmaceuticals, Inc. (US:TERN) valued at $42,452,042 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 664,444 shares of Terns Pharmaceuticals, Inc.. This represents a change in shares of 21.19% during the quarter. The current value of the position is $42,637,246 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F TERNS PHARMACEUTICALS COM 880881107 805,236 140,792 21.19 42,452 58.15 0.0012
2026-02-17 2025-12-31 13F TERNS PHARMACEUTICALS COM 880881107 664,444 76,899 13.09 26,844 508.41 0.0007
2025-11-14 2025-09-30 13F TERNS PHARMACEUTICALS COM 880881107 587,545 16,764 2.94 4,412 107.23 0.0001
2025-08-13 2025-06-30 13F TERNS PHARMACEUTICALS COM 880881107 570,781 -13,407 -2.29 2,129 32.07 0.0003
2025-05-13 2025-03-31 13F TERNS PHARMACEUTICALS COM 880881107 584,188 -6,983 -1.18 1,612 -50.78 0.0002
2025-02-14 2024-12-31 13F TERNS PHARMACEUTICALS COM 880881107 591,171 127,296 27.44 3,275 -15.33 0.0005
2024-11-13 2024-09-30 13F TERNS PHARMACEUTICALS COM 880881107 463,875 116,108 33.39 3,869 63.34 0.0006
2024-08-14 2024-06-30 13F TERNS PHARMACEUTICALS COM 880881107 347,767 -8,029 -2.26 2,368 1.46 0.0004
2024-05-14 2024-03-31 13F TERNS PHARMACEUTICALS COM 880881107 355,796 -2,708 -0.76 2,334 0.34 0.0004
2024-02-13 2023-12-31 13F TERNS PHARMACEUTICALS COM 880881107 358,504 10,184 2.92 2,327 32.76 0.0004
2023-11-13 2023-09-30 13F TERNS PHARMACEUTICALS COM 880881107 348,320 -13,295 -3.68 1,752 -44.63 0.0003
2023-08-11 2023-06-30 13F TERNS PHARMACEUTICALS COM 880881107 361,615 306,536 556.54 3,164 385.28 0.0006
2023-05-15 2023-03-31 13F TERNS PHARMACEUTICALS COM 880881107 55,079 23,486 74.34 652 103.12 0.0001
2023-02-13 2022-12-31 13F TERNS PHARMACEUTICALS COM 880881107 31,593 10,089 46.92 322 152.76 0.0001
2022-11-14 2022-09-30 13F TERNS PHARMACEUTICALS COM 880881107 21,504 7,131 49.61 127 252.78 0.0000
2022-08-12 2022-06-30 13F TERNS PHARMACEUTICALS COM 880881107 14,373 -90,449 -86.29 36 -88.42 0.0000
2022-05-13 2022-03-31 13F TERNS PHARMACEUTICALS COM 880881107 104,822 -7,214 -6.44 311 -60.73 0.0001
2022-02-08 2021-12-31 13F TERNS PHARMACEUTICALS COM 880881107 112,036 -4,880 -4.17 792 -35.03 0.0001
2021-11-15 2021-09-30 13F TERNS PHARMACEUTICALS COM 880881107 116,916 30,133 34.72 1,219 14.57 0.0002
2021-08-13 2021-06-30 13F TERNS PHARMACEUTICALS COM 880881107 86,783 -5,004 -5.45 1,064 -47.30 0.0002
2021-05-12 2021-03-31 13F TERNS PHARMACEUTICALS COM 880881107 91,787 91,787 2,019 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.